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We report the draft genome of Streptomyces rimosus (ATCC 10970), a soil isolate that produces oxytetracycline, a commercially
important and clinically useful antibiotic.
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Streptomyces rimosus is a Gram-positive, aerobic, filamentousactinobacterium. It was reported in 1950 and was patented (1)
as the founder strain for the production of the antibiotic oxytet-
racycline (OTC) (2). Recombination was recognized (3) and a
rudimentary genetic map was deduced (4). The pharmaceutical
industry set out to improve the commercial productivity of OTC,
deriving higher-titer genealogies that led to the contemporary in-
dustrial strains that are now responsible for the production of
108 kg ofOTC annually. Stimulated by commercial interest over
the years, a sophisticated genetics andmolecular biology has been
developed for S. rimosus (5). This announcement reports the der-
ivation of data to enable the generation of a scaffold genome se-
quence for this important industrial species.
Genome sequencing of the S. rimosus type strain ATCC 10970
was carried out using a whole-genome shotgun sequencing ap-
proach performed on a Roche 454 GS Junior apparatus. Using
three single-ended runs, we obtained 440,253 reads. The reads
were assembled usingGenome Sequencer de novoAssembler (ver-
sion 2.7, Roche), which led to a final assembly of 453 contigs of
500 bp. The total size of the assembly was 9.5Mbp, with a mean
contig size of 21 kbp (average, 17 coverage) and a GC content
of 71.88%. Automatic functional annotation results were ob-
tained using the NCBI Prokaryotic Genome Annotation Pipeline
(http://www.ncbi.nlm.nih.gov/genomes/static/Pipeline.html).
The draft genome of S. rimosus is estimated to have a total of
8,416 protein-coding genes, along with 66 tRNAs. The overall ge-
nome size is consistent with the physical map of S. rimosus, de-
rived by pulsed-field gel electrophoresis (6). It is also within the
range of other published streptomycete genome sequences. Three
gene clusters associated with the production of previously re-
ported secondary metabolites [OTC (7), rimocidin (8), and des-
ferrioxamine C (9)] are readily identified within the sequence, in
addition to around 45 other putative secondary metabolite bio-
synthetic clusters whose functions remain to be elucidated (10).
The strain is lysogenic for phages RP2 and RP3, with the DNA
sequences corresponding to the restriction maps published previ-
ously (11). The genome sequence is also likely to include at least
one giant (387 kb) linear plasmid known to be present in S. rimo-
sus (12).
Sequencing of S. rimosusATCC 10970 provides a scaffold from
which to investigate and understand how mutation results in
higher titers of OTC.
Nucleotide sequence accession numbers. The S. rimosus
ATCC 10970 Whole Genome Shotgun project has been
deposited at DDBJ/EMBL/GenBank under the accession no.
ANSJ00000000. The version described in this paper is the first
version, ANSJ01000000.
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